Artwork

Content provided by Jeremy Murphree. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jeremy Murphree or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Hygromycin A for Lyme Disease?

15:08
 
Share
 

Manage episode 453499404 series 2792630
Content provided by Jeremy Murphree. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jeremy Murphree or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Hygromycin A, an antibiotic previously studied for swine dysentery, shows promise in treating Lyme disease and syphilis. Research indicates its high effectiveness against Treponema pallidum, the syphilis bacterium. An American company, FlightPath, is seeking approval for human trials. The antibiotic's advantage lies in its minimal impact on the body's natural microbiome. The article, from a website focused on Lyme disease and Morgellons, highlights this potential breakthrough.

New Antibiotic Could Rid Earth Of Lyme Disease and Chronic Syphilis

  continue reading

54 episodes

Artwork
iconShare
 
Manage episode 453499404 series 2792630
Content provided by Jeremy Murphree. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jeremy Murphree or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Hygromycin A, an antibiotic previously studied for swine dysentery, shows promise in treating Lyme disease and syphilis. Research indicates its high effectiveness against Treponema pallidum, the syphilis bacterium. An American company, FlightPath, is seeking approval for human trials. The antibiotic's advantage lies in its minimal impact on the body's natural microbiome. The article, from a website focused on Lyme disease and Morgellons, highlights this potential breakthrough.

New Antibiotic Could Rid Earth Of Lyme Disease and Chronic Syphilis

  continue reading

54 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play